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Inhaling  carbon  dioxide  (CO2)-enriched  air induces  fear and  panic  symptoms  resembling  real-life  panic
attacks,  the  hallmark  of  panic  disorder.  The  present  study  aimed  to describe  the  emotional  and  cardio-
vascular  effects  evoked  by  inhaling  CO2, taking  shortcomings  of previous  studies  into  account.  Healthy
volunteers  underwent  a double  inhalation  of  0,  9, 17.5,  and  35% CO2, according  to  a randomized,  cross-





were  continuously  monitored.  Results  showed  a dose-dependent  increase  in  all  self-reports.  Systolic  and
diastolic  blood  pressure  rose  with  increasing  CO2 concentration,  whereas  heart  rate  results  were less
consistent.  Diastolic  blood  pressure  and  heart  rate  variation  correlated  with  fear  and  discomfort.  Based
on  this  relationship  and  the  observation  that  the  diastolic  blood  pressure  most  accurately  mimicked  the
degree  of  self-reported  emotions,  it might  serve  as  a putative  biomarker  to assess  the  CO2-reactivity  in
the  future.. Introduction
About 23% of the general population experiences a panic attack
PA) at least once in their lives (Kessler et al., 2006). PAs are
pontaneous periods of irrational intense fear and/or discomfort
ccompanied by respiratory, neurovegetative and cognitive symp-
oms such as shortness of breath, choking, dizziness, palpitations,
hest pain, paresthesias, fear of losing control, and derealization.
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The symptomatic peak is reached within 10 min  after onset of the
attack.
Recurrent PAs form the core of panic disorder (PD). In addition
to PAs, PD is characterized by concerns about future attacks or con-
comitant consequences, often accompanied by behavioral changes
(American Psychiatric Association, 2000). PD has a prevalence of
about 4% in the general population (Weissman et al., 1997) and
is accompanied by a considerable decrease in quality of life and
high health care costs (Andlin-Sobocki & Wittchen, 2005; Olesen,
Gustavsson, Svensson, Wittchen, & Jonsson, 2012). In spite of a large
amount of research into the underlying mechanisms of panic, there
is still no scientific consensus on its pathogenesis.
From a biological point of view, converging evidence points
towards a role of chemosensitivity in the pathophysiology of PAs.
An early theory was  postulated by Klein (1993; Preter & Klein,
2008), stating that every individual is equipped with a phylo-
genetically evolved suffocation alarm system that is sensitive to
metabolic threats from bodily origin (e.g., CO2 levels and CO2-
induced changes in pH). When activated, the individual is alerted
of imminent asphyxia, leading to an emotional and behavioral































































32 N.K. Leibold et al. / Biologica
ystem, however, signals a vital threat without the presence of a
eal danger. In other words, according to Klein’s theory, PAs are
alse alarms due to a dysfunctional suffocation detection. However,
 neural substrate for that suffocation detector system remains to
e elucidated.
On a molecular level, it has been shown that brainstem seroto-
ergic cells act as chemosensors that detect a decrease in pH due to
n increased concentration of CO2 (Corcoran et al., 2009; Richerson,
004; Severson, Wang, Pieribone, Dohle, & Richerson, 2003). These
erotonergic cells are closely associated with large arteries, thereby
eing ideally situated to sense arterial blood CO2 levels and to initi-
te behavioral and autonomic responses aimed at maintaining pH
omeostasis (Bradley et al., 2002). As projection areas of these cells
nclude the limbic system, it has been suggested that these sero-
onergic cells are involved in the affective response to CO2. In this
espect, these cells may  mediate arousal and feelings of anxiety and
uffocation to CO2 (Richerson, 2004).
A recent study further increased the insights into the mecha-
isms underlying the effects of CO2. In this rodent study, it was
emonstrated that the acid-sensing ion channel 1a (ASIC1a) also
etects changes in pH. Exposure to CO2 was shown to reduce the
H within the amygdala, which activates amygdalar ASIC1a that,
n turn, is strongly involved in triggering fear behavior (Ziemann
t al., 2009). These data are in accordance with a previous hypoth-
sis that PAs might involve an acute disturbance in the acid-base
alance in certain brain areas (Esquivel, Schruers, Maddock,
olasanti, & Griez, 2010).
We have previously proposed (in line with Denton, 2006;
enton, McKinley, Farrell, & Egan, 2009) that PAs can be consid-
red as the expression of an emotion aimed at maintaining the
ndividual’s homeostasis. In this view, emotions consist of two
omponents, namely sensation and intention. Sensation is the
onscious perception of disturbed bodily functions, stimulating
n adaptive response (intention). When the sensation is evoked
y internal body states (i.e., interoceptor driven) and is linked to
urvival, thus signaling that the organism’s existence is instantly
hreatened, the emotion may  pervade the conscious awareness
s primal emotion (Colasanti, Esquivel, Schruers, & Griez, 2012;
enton, 2006; Denton et al., 2009). In this respect, we believe that
As are rooted in instinctual behavior and are an instance of primal
motion to protect the individual against a vital threat. Therefore,
t would be meaningless to assess PAs using exclusively biological
r psychological measures.
PAs can be reliably provoked in the laboratory. Numerous phar-
acological substances and other techniques have been used (for
eview see Esquivel, Schruers, & Griez, 2008), of which some
nfluence the acid-base homeostasis: voluntary hyperventilation,
actate infusions, and carbon dioxide (CO2) inhalations.
When comparing the different methods, it is apparent that CO2
nhalation has a number of advantages, which made it an often
pplied and well-established experimental model for human panic
uring the last few decades. CO2 inhalation is a relatively easy,
on-invasive, safe, and reliable technique to trigger intense, but
hort-lasting, fear and panic symptoms in PD patients (e.g., Nardi
t al., 2006; Perna, di Bella, et al., 2004; Verburg, Griez, Meijer, &
ols, 1995; Verburg, Pols, de Leeuw, & Griez, 1998). These sensa-
ions closely resemble the symptomatology of naturally occurring
As (Nardi et al., 2006; Schruers, van de Mortel, Overbeek, & Griez,
004). Over the last few years, it has been shown that panic can also
e induced in healthy subjects by inhaling CO2. More specifically,
O2 dose-dependently elicits negative affect, provoking the emo-
ional and physical sensations of a PA in accordance with the formal
SM-IV criteria, particularly when using a double vital capacity
reath of 35% CO2 (Colasanti et al., 2008; Griez, Colasanti, van
iest, Salamon, & Schruers, 2007; Schruers et al., 2011). These stud-
es demonstrate that panic symptoms can, to a differing extent,hology 94 (2013) 331– 340
be triggered in most individuals, depending on the concentra-
tion of CO2 used. This implies the existence of a CO2-reactivity
continuum and that the response to CO2 is based on a common
mechanism. Therefore, studying healthy volunteers can provide
important insights into the fundamental mechanisms underlying
CO2-reactivity. Additional reasons to investigate the basic mech-
anisms of panic in healthy volunteers are the high comorbidity
with other psychiatric disorders and the frequent use of med-
ication by PD patients, both of which may  mask the effects of
interest.
The response to CO2 is commonly measured using self-reports
on the presence and intensity of fear and panic symptoms. PAs are
accompanied by profound physiological symptoms that are also
classically assessed by self-reports. A primal emotion consists of
the conscious perception of disturbed bodily function as well as
an adaptive homeostatic response. The former can be reported
by the individual, whereas the latter is not completely covered
by self-reports. Therefore, focusing on the classical self-reports
seems too narrow to examine a PA in all its aspects. Incorpo-
rating physiological measures may  be an important approach
to assess the homeostatic response and to complement self-
ratings, thereby refining the assessment and diagnosis of PAs. In
recent years, various (psycho)physiological parameters have been
increasingly included (e.g., Bailey, Argyropoulos, Kendrick, & Nutt,
2005; Blechert, Wilhelm, Meuret, Wilhelm, & Roth, 2010, 2013;
Bystritsky, Craske, Maidenberg, Vapnik, & Shapiro, 2000; Gorman
et al., 2001; Papadopoulos, Rich, Nutt, & Bailey, 2010; Pappens, De
Peuter, Vansteenwegen, Van den Bergh, & Van Diest, 2012; Poma
et al., 2005).
When focusing on the cardiovascular system, blood pressure
and heart rate are the parameters of interest. More than two
decades ago, some attempts were already made to include those
measurements to assess the cardiovascular response to a CO2
inhalation. For instance, in PD patients and controls, Gorman et al.
(1990) did not find any significant alteration in blood pressure after
inhaling 35% CO2. Similarly, Bystritsky and Shapiro (1992) did not
observe any blood pressure response in healthy subjects, when
inhaling a low dosage of 5.5% CO2. However, small sample sizes
and analyzing means over prolonged periods of time (Gorman et al.,
1990) limit the generalizability of these results. Using larger sam-
ples, other research groups did report CO2-induced increases in
blood pressure (Martinez et al., 1998) and heart rate (Martinez et al.,
1998; Poonai et al., 2000). Using more advanced beat-to-beat moni-
toring revealed that 35% CO2 elicited a relative rise in systolic blood
pressure, whereas heart rate was  not affected, when comparing the
change between 10 s before to 10 s after the CO2 inhalation. Analyz-
ing the first post-inhalation minute showed a relative CO2-induced
rise of the systolic blood pressure, concomitant with an overall
decrease of heart rate, possibly compensatory to the elevated blood
pressure (Argyropoulos et al., 2002). A correlation analysis on these
data yielded no significant relationship between cardiovascular
parameters and self-reported fear (Bailey, Argyropoulos, Lightman,
& Nutt, 2003). Further, in other studies, an increase in systolic
(Bailey et al., 2005; Kaye et al., 2004; Wetherell et al., 2006), but
not diastolic (Bailey et al., 2005; Kaye et al., 2004), blood pressure
was reported after inhaling CO2-enriched air. Assessing heart rate
yielded inconsistent results in these studies, with reports on a pos-
itive (Bailey et al., 2005) and negative (Kaye et al., 2004; Wetherell
et al., 2006) effect of a CO2 inhalation. In contrast, more recent
studies observed an increase in heart rate (Nillni, Berenz, Rohan,
& Zvolensky, 2012; Papadopoulos et al., 2010; Richey, Schmidt,
Hofmann, & Timpano, 2010), but diverge regarding the effects of
CO2 on blood pressure. Papadopoulos et al. (2010) did not find any
effect caused by inhaling 7.5% CO2, whereas Richey et al. (2010)
reported an increase in systolic as well as diastolic blood pressure
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Taken together, the results of studies assessing the cardio-
ascular physiology in response to a CO2 inhalation are fairly
nconsistent, which may  be explained by several identifiable
ariations and shortcomings in terms of methodology, technical
quipment, and performed analyses. For instance, an insufficient
umber of measurements over time accompanied by analyzing
verall means or means over several seconds (e.g., Gorman et al.,
990) masks time courses and brief fluctuations, which are of
mportance to gain more insight into a short-lived phenomenon
uch as panic. Similarly to early studies, more recent studies
mploying beat-to-beat measurements frequently used small sam-
le sizes and/or focused on a single concentration of CO2 (e.g.,
rgyropoulos et al., 2002; Bailey et al., 2003, 2005; Papadopoulos
t al., 2010). In addition to methodological issues, confounders may
lso contribute to varying results. For instance, it has been reported
hat the CO2-reactivity decreases with age (Griez et al., 2007), indi-
ating the importance of a large sample size and/or restriction of
he sample’s age range. Other possible confounders include, for
nstance, smoking (Abrams et al., 2008; Knuts et al., 2010), caffeine
ntake (Nardi et al., 2007; Vilarim, Rocha Araujo, & Nardi, 2011),
lcohol use (Cosci, De Gooyer, Schruers, Faravelli, & Griez, 2005;
ushner et al., 1996), and physical exercise (Esquivel et al., 2012;
mits, Meuret, Zvolensky, Rosenfield, & Seidel, 2009).
The objective of the present study was to describe the emotional
nd cardiovascular response to CO2 to assess the psychobiological
henomenon PA in all its aspects, taking the abovementioned iden-
ifiable shortcomings of previous studies into account, and thereby
efining the assessment of PAs. Accordingly, to investigate the
esponse to CO2 in more detail, we challenged 120 healthy volun-
eers with four different CO2 concentrations that have been proven
o evoke a dose-dependent increase in negative affect. In addition
o the commonly used self-reports, we used a computerized system
hat allowed continuous and accurate monitoring of the physiolog-
cal parameters blood pressure and heart rate throughout the entire
rocedure. Of note, both parameters were previously validated in
 pilot study. We  hypothesized that the cardiovascular measures
ould mimic  the degree of self-reported fear, discomfort, and panic
ymptoms.
. Materials and methods
.1. Subjects
One hundred and twenty healthy volunteers participated in this study (35
ales, 85 females, mean age 24.01 years, SD = 7.24). Subjects were recruited via
dvertisements at Maastricht University, the Netherlands, to ensure a homogenous
ample in terms of age (Griez et al., 2007). All potential subjects were screened
y  an experienced psychiatrist or psychologist using a routine medical examina-
ion and the Mini International Neuropsychiatric Interview (M.I.N.I., Sheehan et al.,
998). Inclusion criteria were age between 18 and 65 years, and a good past and
resent physical as well as mental condition. Exclusion criteria were current or past
ulmonary or cardiovascular disease, current hypertension (systolic > 170 mmHg,
iastolic > 100 mmHg), cerebral aneurysm, pregnancy, epilepsy, excessive smoking
>15 cigarettes/day), use of adrenergic receptor blockers or psychotropic medica-
ion, and having a first-degree relative suffering from PD. Subjects were instructed
o  refrain from coffee on the test days. Each subject gave written informed consent
ccording to the principles of the Declaration of Helsinki. A financial compensation
as  paid for participation. The study was approved by the Medical Ethics Committee
f  Maastricht University and the Maastricht University Hospital.
.2. Procedure
The study was  performed as previously described (Griez et al., 2007; Schruers
t  al., 2011; Verburg, Perna, & Griez, 2001) and extended by physiological measure-
ents (see Section 2.4). Using a randomized, cross-over design, subjects underwent
 standardized double inhalation of four CO2 concentrations: 0% (room air), 9%, 17.5%
nd 35% CO2. Each mixture also contained 20% O2 and 80%, 71%, 62.5%, or 55% N2,
espectively. Subjects were seated in a comfortable armchair during the entire pro-
edure. A soft plastic nasal-oral mask, connected to a capnograph (medair, Delsbo,
weden) and a computer, was fixed to the subjects’ head. First, the vital capacity
f a double breath was  measured using a flowmeter. Subjects were instructed to
xhale to the maximum, to inhale as much as possible, to exhale and inhale to thehology 94 (2013) 331– 340 333
maximum again, and to hold their breath for 4 s (to increase alveolar gas exchange).
Subsequently, the CO2 inhalation took place. Subjects were told that the following
breath of the CO2 mixture may  cause effects, ranging from some vague sensations
up  to fear, depending on the CO2 concentration and the individual susceptibility.
However, all sensations would be short-lived. The words ‘panic attack’ were not
mentioned to avoid cognitive bias due to expectation. The inhalation procedure
was  identical to the one previously used for assessing the double breath vital capac-
ity, including the use of the same flowmeter to motivate the subjects to inhale at
least 80% of the measured vital capacity. Inhalations took place on four separate
days, each day at the same time for each subject, to avoid effects of fluctuations in
circadian rhythms.
2.3. Self-report measures
Self-reports were assessed in accordance with the DSM-IV criteria, which define
a  PA as ‘a discrete period of intense fear or discomfort’, accompanied by at least 4 out
of  13 defined symptoms that develop abruptly and reach a peak within 10 min  after
onset (American Psychiatric Association, 2000). In line with this definition, subjects
were asked to evaluate their subjective feeling of fear and discomfort by means
of  a Visual Analogue Scale (VAS-Fear and VAS-Discomfort, respectively). The scale
consists of a horizontal line of 100 mm length and ranges from 0 (not at all) to 100
(the worst imaginable). Panic symptoms were evaluated using the Panic Symptom
List  (PSL)-IV, which lists the 13 symptoms characterizing a PA according to the DSM-
IV criteria such as palpitations, shortness of breath, feeling of chocking, dizziness,
and fear of losing control or of dying. The list ranges from 0 (absent) to 4 (very
intense).
Self-reports were obtained immediately before (how the subjects felt at that
particular moment) and immediately after the CO2 inhalation (how the subjects felt
at  the worst moment of the inhalation) (Schruers et al., 2011). An increase of at least
25  in the fear or discomfort rating in combination with an increase of at least four
points in the panic symptom rating was defined as occurrence of a PA (Esquivel et al.,
2012).
2.4. Cardiovascular measures
Blood pressure and heart rate were continuously measured throughout the
entire procedure (baseline, CO2 inhalation, recovery) using a computerized system
(Carbon Dioxide Tolerance Tester, CTT, Maastricht Instruments B.V., Maastricht, The
Netherlands). A finger cuff was attached to the mid-phalanx of the third finger of the
non-dominant hand and was connected to a cardiovascular monitor (Nexfin, bmeye
BV,  Amsterdam, The Netherlands) and a computer equipped with the software CO2
Challenge (IDEEQ, Maastricht Instruments B.V., Maastricht, The Netherlands). All
measurements were calibrated and subsequently recorded using a sampling rate of
2  Hz. To minimize movements, the hand rested on the arm of the chair.
The parameters of interest were chosen based on a previous pilot study (unpub-
lished data), in which we assessed blood pressure, heart rate, various respiratory
parameters, skin conductance, and pupil diameter in response to inhaling 35% CO2.
Blood pressure and heart rate appeared to be the most sensitive outcome parame-
ters  (in addition to respiration rate and end-tidal CO2, which were also measured
but  will be discussed in a separate paper) and were incorporated in a customized
computerized system prior to this study.
2.5. Statistical analysis
Due to technical failure in the physiological monitoring in at least one of the four
CO2 concentrations, 16 subjects were excluded. The final sample for all analyses with
regard to physiology consisted, therefore, of 104 subjects (30 males, mean age 24.57
years, SD = 7.21; 74 females mean age 23.20 years, SD = 6.01). Changes (pre-score
subtracted from post-score) in fear, discomfort, and panic symptoms across the four
CO2 concentration levels were examined by means of multilevel models (with the
four responses nested within subjects) with an unstructured variance–covariance
matrix to account for the fact that the same subjects were tested under all four
conditions. A significant overall test suggesting differences between at least two  of
the  four CO2 concentration levels was  followed up by tests of all pairwise differences
using Holm’s method to control the familywise error rate (Holm, 1979).
Physiological measures were analyzed in terms of systolic and diastolic blood
pressure and heart rate. To reduce the amount of data, we first used locally weighted
polynomial regression (Cleveland & Devlin, 1988) for the data of each subject in
order to avoid strong effects of outliers. Based on the smoothed data, we  then calcu-
lated the area under the curve (AUC), peak, and range (peak minus minimum) within
the  first 60 s after inhaling the second breath of CO2 (see Supplementary Fig. 1 for
an  illustration of the outcomes). In addition, the amount of fluctuations around the
smoothed data (standard deviation, SD) was calculated. To avoid confusion with the
term “heart rate variability”, which is usually assessed by means of spectrum or spec-
tral analysis, fluctuations are denoted as “variation”. These derived outcomes were
then  again analyzed with multilevel models as described previously. A log transfor-
mation was  applied to the outcome variation to obtain residual distributions closer
to  normality.
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Fig. 1. Effects of increasing CO2 concentrations on the change in fear (VAS-F, top left), discomfort (VAS-D, top right) and panic symptoms (PSL, bottom). A main effect of CO2
c ultilev

































oncentration on fear, discomfort and panic symptoms was  observed (p < 0.001, m
p  < 0.001, except for fear and discomfort when comparing 9% to 0%, p = 0.006 and p
esting). Bars represent mean change + standard error of the mean.
Effect sizes (Cohen’s d) were calculated using standardized mean gains, indicat-
ng  the change in the mean standardized by the standard deviation of the scores for
he lower CO2 concentration (Becker, 1988).
To assess the proportion of subjects who did not recover, that is, who  did not
eturn to a stable blood pressure or heart rate within 60 s after inhaling CO2, we
tted rolling regression models to the data with a 20 s window. Within each time
indow, the slope of the regression line and the residual standard deviation were
btained. Stability was defined as the first 20 s window, in which the slope was
elow 0.10 in absolute value and the residual SD below 5.0 (see Supplementary Fig.
). Then, Cox proportional hazard models were applied, in which robust estimators
f  the standard errors were used to account for the fact that subjects were measured
n  all four CO2 concentrations. When significant, main effects were further analyzed
y  means of pairwise comparisons using Holm’s method.
Correlation analyses between the change in self-reports and the derived car-
iovascular outcome measures were performed using a permutation test, which
ccounts for the fact that each subject took part in all four CO2 inhalations, thereby
eading to dependent values. First, the blocks of four values belonging to the same
ubjects were permutated. Subsequently, the four values were permutated within
ach block for each subject. This process was repeated 100,000 times, after which the
roportion of correlations that were more extreme than the observed correlation
as  calculated.
To examine whether the presence of any carry-over effects may have influenced
he  conclusions of the previous analyses, a four-level factor was coded that indicated
he sequence of treatments given (Senn, 2002). This factor was  included in the model
ogether with its interaction with the factor of the actual CO2 concentration.
All presented p-values are already adjusted for multiple testing. For all analyses,
ignificance was set at p < 0.05. Statistical analyses were performed using the soft-
are R (version 2.14.0, 2011, R Development Core Team, Vienna/Austria). For the
ultilevel models, the nlme package was  used (version 3.1-102).
. Results
.1. Effects of CO2 on self-report measures
A significant main effect of CO2 concentration on subjective
ear, discomfort, and panic symptoms (p < 0.001) was present. The
O2-induced increase in all self-report measures was strongly
ose-dependent (p < 0.001, except for fear and discomfort when
omparing 9% to 0%: p = 0.006 and p = 0.015, respectively) (Fig. 1).
here was no effect of sex on self-report measures. The panic rates,el models). CO2 increased both emotions and panic symptoms dose-dependently
5, respectively; pairwise comparisons using Holm’s method, corrected for multiple
defined as an increase of at least 25 in fear or discomfort in addition
to an increase of at least four points on the panic symptom scale,
were 46.67% and 67.5% for fear and discomfort, respectively.
3.2. Effects of CO2 on cardiovascular measures
A variety of outcome measures of the systolic and diastolic blood
pressure as well as heart rate was analyzed in response to 0%, 9%,
17.5%, and 35% CO2 (Supplement, Fig. 1, one subject for illustration).
In general, with regard to both systolic and diastolic blood pressure,
the AUC, peak and time needed to return to a stable level increased
dose-dependently. In contrast, only minor effects of CO2 concentra-
tion on heart rate were observed. The results of the group means
with regard to the AUC, peak, range, and proportion of subjects that
did not recover as well as variation within a 60 s phase after the CO2
inhalation are presented in the following subsections. Women  had
a lower blood pressure after inhaling 0% CO2. However, since the
increases in response to CO2-enriched air were not statistically dif-
ferent between women and men, the physiological effects are not
presented per sex. Analyses of carry-over effects did not indicate
any significant effects.
3.2.1. Systolic blood pressure
Effects of increasing CO2 concentrations on group means of the
systolic blood pressure over time (means per second) are depicted
in Fig. 2 (top panel), showing that CO2 induced a brief drop in the
first seconds, followed by a rise and another brief drop. Approx-
imately 8 s after inhaling CO2 an abrupt rise occurred, reaching
a peak, followed by quickly declining levels until stability was
reached. These effects were dose-dependent until 17.5% CO2. How-
ever, the time to return to a stable systolic blood pressure was
longer in the 35% CO2 condition in comparison with all other CO2
dosages.
Analysis of the derived cardiovascular outcomes (based on the
60 s recovery phase starting immediately after the second breath
N.K. Leibold et al. / Biological Psyc
Table  1
Effects of increasing CO2 concentrations on the mean peak, range, and on the varia-
tion of the systolic as well as diastolic blood pressure and heart rate within the 60 s
after the inhalation. Values represent means over the entire analyzed 60 s phase.





Peak 0 135 83 109
9  146 89 109
17.5  156 97 108
35  156 100 107
Range 0  44 32 43
9  45 29 45
17.5  55 37 48
35  57 42 49
Variation 0  0.16 −0.15 0.23


























17.5  0.45 0.30 0.78
35  0.62 0.51 1.03
f CO2) revealed a main effect of CO2 concentration on the systolic
UC (p < 0.001) and the CO2-induced peak (p < 0.001). The increase
n the systolic AUC as well as the peak was dose-dependent until
7.5% CO2, indicating reaching a plateau (see Table 1 for means and
able 2 for all p-values and effect sizes). Further, an overall effect
f CO2 dosage was observed concerning the range of the systolic
lood pressure (p < 0.001). Multiple comparisons revealed that 0%
nd 9%, not different from one another (p = 0.833), induced a signif-
cantly smaller range than 17.5% (both p < 0.001) and 35% CO2 (both
 < 0.001). The proportion of subjects who did not recover within
0 s after the CO2 inhalation was also dependent on the CO2 concen-
ration (main effect p < 0.001) (Supplement, Fig. 2, top panel, left).
he highest proportions, i.e., the lowest number of subjects who
id not recover within the 60 s time window, were observed after
nhaling 17.5% and 35% CO2 (Supplement, see Table 1 for means
nd Table 2 for p-values). Similarly to the previous analyses, a main
ffect of CO2 concentration on variation was observed (p < 0.001),
ith a relative increase in variation with increasing dosage of CO2
osage..2.2. Diastolic blood pressure
Effects of increasing CO2 concentrations on group means (per
econd) of the diastolic blood pressure are shown in Fig. 2 (middle
able 2
ffects of increasing CO2 concentrations on the mean AUC, peak, range, proportion who d
ate  within the 60 s phase after the inhalation. Values represent p-values (pairwise compa
,  standardized mean gains; bold).
Systolic blood pressure Diastolic blood press
AUC
% CO2 0 9 17.5 35 0 9 
0  – 0.41 0.71 0.88 – 0.44
9  0.002 – 0.26 0.4 <0.001 – 
17.5  <0.001 0.026 – 0.14 <0.001 0.01
35  <0.001 0.005 0.187 – <0.001 <0.0
Peak
0  – 0.65 1.2 1.21 – 0.57
9  <0.001 – 0.44 0.45 <0.001 – 
17.5  <0.001 <0.001 – 0.01 <0.001 <0.0
35  <0.001 0.003 0.912 – <0.001 <0.0
Range
0  – 0.09 0.77 0.88 – −0.
9  0.833 – 0.63 0.73 0.002 – 
17.5  <0.001 <0.001 – 0.1 <0.001 <0.0
35  <0.001 <0.001 0.833 – <0.001 <0.0
Variation
0  – 0.75 0.92 1.49 – 0.66
9  <0.001 – 0.13 0.55 <0.001 – 
17.5  <0.001 0.251 – 0.46 <0.001 <0.0
35  <0.001 <0.001 <0.001 – <0.001 <0.0hology 94 (2013) 331– 340 335
panel). Similar to the systolic blood pressure, CO2 caused two brief
declines within the first 8 s, after which a steep dose-dependent rise
eventually reaching a peak was  observed. This was  followed by a
decrease until stable levels were reached. In addition, after inhaling
35% CO2, it took longer to return to a stable level compared to lower
CO2 concentrations.
Within the 60 s recovery phase after the double breath of CO2, an
overall effect of CO2 concentration on the AUC of the diastolic blood
pressure (p < 0.001) and on the CO2-elicited peak was  observed
(p < 0.001). CO2 caused a dose-dependent rise in the diastolic AUC
and peak. However, with respect to the peak, a plateau was reached
at 17.5% CO2 (see Table 1 for means and Table 2 for p-values and
effect sizes). A main effect of CO2 was also observed in the range
of the diastolic blood pressure (p < 0.001), with an increase in the
range when inhaling higher concentrations of CO2. In addition,
all ranges differed significantly from one another. Further, anal-
ysis of the proportion of subjects that did not recover within 60 s
after inhaling CO2 (overall effect p < 0.001) revealed that most of
the subjects did return to a stable diastolic blood pressure after
inhaling 0% and 9% CO2 (Supplement, Fig. 2, top panel, right). This
proportion was  strongly reduced after inhaling 17.5% and partic-
ularly 35% CO2 (Supplement, see Table 1 for means and Table
2 for p-values). An overall effect of CO2 concentration was also
present on the variation of the diastolic blood pressure (p < 0.001).
The rise in variation showed a distinct dose-dependent pattern
(all p < 0.001).
3.2.3. Heart rate
Effects of increasing CO2 concentrations on mean heart rate
before, during, and after the CO2 inhalation (mean per second)
are illustrated in Fig. 2 (bottom panel). CO2 caused a brief rise for
about 3 s, followed by a drop and another, though slightly longer,
rise after about 9–16 s. Subsequently, heart rate promptly returned
to a stable level. In contrast to blood pressure, no dose-dependent
relationship was  present.
With regard to the analysis of the 60 s phase after inhaling
CO2, the observed main effect of CO2 concentration on the AUC
of the heart rate was highly significant (p < 0.001). Interestingly,
inhaling 17.5% CO2 showed the smallest AUC compared to all
other CO2 concentrations (see Table 1 for means and Table 2 for
p-values and effect sizes). No significant overall effect regarding
a CO2-elicited heart rate peak was present. With respect to the
id not recover, and variation of the systolic and diastolic blood pressure and heart
risons using Holm’s method, corrected for multiple testing) or effect sizes (Cohen’s
ure Heart rate
17.5 35 0 9 17.5 35
 0.75 1.00 – −0.14 −0.43 −0.2
0.26 0.46 0.211 – −0.29 −0.06
4 – 0.21 <0.001 0.002 – 0.25
01 0.027 – 0.105 0.552 0.016 –
 1.44 1.72 – 0.04 −0.07 −0.08
0.66 0.88 1.000 – −0.11 −0.13
01 – 0.19 1.000 0.736 – −0.01
01 0.092 – 1.000 1.000 1.000 –
35 0.61 1.12 – 0.19 0.38 0.46
0.51 1.04 0.133 – 0.19 0.26
01 – 0.44 <0.001 0.133 – 0.07
01 0.002 – 0.001 0.133 0.511 –
 1.15 1.67 – 0.65 1.03 1.5
0.51 1.04 <0.001 – 0.41 0.91
01 – 0.44 <0.001 <0.001 – 0.53
01 <0.001 – <0.001 <0.001 <0.001 –
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Fig. 2. Effects of increasing concentrations of CO2 on mean systolic blood pressure
(top panel), diastolic blood pressure (middle panel), and heart rate (bottom panel)
over time (means per second). The dashed line indicates the end of a double breath
of  CO2. Top panel: Inhaling CO2 induced two  brief decreases in systolic blood pres-
sure, after which a rise could be observed, followed by a recovery phase in which the
blood pressure returned to stable levels. The effect of CO2 was  dose-dependently,
with the exception of 35% CO2, which caused a lower systolic blood pressure peak
than 17.5% CO2. However, at 35%, the systolic blood pressure took longer to return to
a  stable level compared to the other CO2 concentrations. Middle panel: CO2 induced
two short decreases in diastolic blood pressure, after which the levels increased
dose-dependently until reaching a peak, similar to the systolic blood pressure. Sub-
sequently, the diastolic blood pressure decreased again, eventually reaching stable



















Correlations (represented as R-values) and corresponding p-values (permutation
test) between mean change in fear (VAS-F), discomfort (VAS-D), and panic symp-
toms (PSL) and the outcome measures of the diastolic cardiovascular outcome









R  0.22 0.19 0.19
p-Value 0.009** 0.069 0.098
Peak
R  0.24 0.19 0.22
p-Value 0.013* 0.190 0.139
Range
R  0.21 0.19 0.26
p-Value 0.053 0.163 0.047*
Variation
R 0.16 0.23 0.26
p-Value 0.138 0.074 0.036*
Diastolic blood pressure
AUC
R 0.24 0.25 0.23
p-Value 0.006** 0.013* 0.066
Peak
R  0.34 0.31 0.33
p-Value 0.002** 0.037* 0.065
Range
R  0.29 0.29 0.36
p-Value 0.021* 0.078 0.023*
Variation
R 0.32 0.36 0.39
p-Value 0.016* 0.012* 0.013*
Heart rate
AUC
R  0.04 −0.07 −0.03
p-Value 0.56 0.38 0.69
Peak
R  0.06 −0.03 0.00
p-Value 0.21 0.47 0.96
Range
R  0.13 0.14 0.18
p-Value 0.051 0.050* 0.007**
Variation
R 0.34 0.39 0.43
p-Value 0.006** 0.003** <0.001***
* p < 0.05.
** p < 0.01.hich a drop, followed by second, longer rise could be observed. Subsequently, heart
ate quickly returned to a stable level. CO2-induced alterations in heart rate were
ot dose-dependent.
ange of the heart rate, a main effect of CO2 dosage was observed
p < 0.001). Pairwise comparisons using Holm’s method revealed
hat inhalation of the two highest CO2 concentrations, i.e., 17.5%
nd 35%, was associated with an increased range compared to
% CO2 (p < 0.001 and p = 0.001, respectively). A main effect was
lso present regarding the proportion of subjects that did not
ecover within 60 s after the inhalation (p = 0.001) (Supplement,
ig. 2, bottom panel), indicating that all CO2 concentrations
esulted in a larger proportion compared to the 0% condition
Supplement, see Table 1 for means and Table 2 for p-values).
urthermore, an overall effect of CO2 dosage on heart rate variation
as found (p < 0.001), with a dose-dependent rise in variation.
ffects of all CO2 dosages differed significantly from one another
all p < 0.001).*** p < 0.001.
3.3. Correlation analyses between self-reports and cardiovascular
outcomes
Correlation analyses between the change in fear, discomfort, and
panic symptoms, and the cardiovascular outcomes revealed sev-
eral significant correlations (see Table 3 for an overview). Both the
AUC and the peak of the systolic blood pressure were significantly
correlated with fear only (R = 0.22, p = 0.009 and R = 0.24, p = 0.013,
respectively). The range as well as the variation in systolic blood
pressure was correlated with panic symptoms (R = 0.26, p = 0.047
and R = 0.26, p = 0.036, respectively). Additionally, all outcomes
of the diastolic blood pressure were significantly correlated with
fear, in particular the AUC and the peak diastolic blood pressure
(R = 0.24, p = 0.006 and R = 0.34, p = 0.002, respectively). Moreover,
most outcomes of the diastolic blood pressure also correlated with
discomfort. With regard to heart rate, strong correlations were
found between the heart rate variation and fear (R = 0.34, p = 0.006),
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. Discussion
In the present study we aimed to describe the emotional and
ardiovascular effects provoked by four different concentrations
f CO2, ranging from 0% (room air) to 35% CO2, in a large sample
f healthy volunteers. In addition to replicating a dose-dependent
ear response to CO2, we substantially extended our previous stud-
es by including continuous monitoring of cardiovascular effects.
he results show CO2-induced increases in most outcomes of the
lood pressure, with highest discriminability for the diastolic blood
ressure. Heart rate was  mainly affected in terms of variation. Cor-
elation analyses revealed a significant relationship between fear
nd heart rate variation as well as several outcome measures of the
iastolic blood pressure.
.1. Effects of CO2 on self-reports
CO2 proved to provoke an immediate dose-dependent increase
f fear, discomfort, and panic symptoms. This observation is con-
istent with previous studies by our group, demonstrating that
ncreasing concentrations of CO2 are associated with increased
egative affect in healthy subjects. Particularly 35% CO2 has been
hown to be an effective dosage to induce the emotions and
ymptoms associated with naturally occurring PAs in PD patients,
onforming to the DSM-IV criteria for PAs (Griez et al., 2007;
chruers et al., 2011). In this respect, this study corroborates the
se of CO2 as a reliable, fast, and relatively simple laboratory model
or PAs.
Further, no sex differences were found. This result diverges from
pidemiological data showing that women are more often affected
y PD than men  (Dick, Bland, & Newman, 1994; Gater et al., 1998).
revious research failed to show consistent results with regard
o sex differences in CO2-reactivity. While some research groups
id report more fear and panic (Kelly, Forsyth, & Karekla, 2006),
tronger increases in anxiety (Bunaciu, Feldner, Babson, Zvolensky,
 Eifert, 2012) or higher levels of panic symptoms (Nillni et al.,
012) in women compared to men, others did not find a sex effect
Griez et al., 2007; Nardi et al., 2007; Perna, Caldirola, et al., 2004;
oonai et al., 2000). It has been proposed that environmental fac-
ors such as socializing may  prime women to be more likely to
eport distress, whilst fearful behavior may  be less accepted in men
McLean & Anderson, 2009). Other factors such as anxiety sensitiv-
ty (Schmidt & Zvolensky, 2007), which were not assessed in the
resent study, may  also play a confounding role.
.2. Effects of CO2 on cardiovascular outcomes
In the present study, an immediate activation of the auto-
omic nervous system in response to CO2 was observed, with a
apid increase in both systolic and diastolic blood pressure. Except
or variation, the outcome measures of the systolic blood pres-
ure showed no statistical difference between 17.5% and 35% CO2,
hough subjective emotions and panic symptoms increased dose-
ependently, which was well mimicked by the diastolic blood
ressure. These diverging results may  be explained by a ceiling
ffect in the case of the systolic blood pressure. Further, these
bservations also imply that diastolic blood pressure has a better
iscriminability and higher sensitivity compared to systolic blood
ressure and is therefore preferable in analyzing the reactivity to
O2. Notably, no carry-over effects were present for any outcome
easure, implying that the effects of the CO2 concentrations were
ot affected by the order given.
Since this is the first study that assessed both the emotional and
ardiovascular response to 0%, 9%, 17.5%, and 35% CO2, and ana-
yzed a variety of physiological outcomes, we are unable to directly
ompare these outcome measures with previous studies. However,hology 94 (2013) 331– 340 337
general effects of CO2 inhalations have been described previously.
The 35% CO2-induced rise in systolic blood pressure is consistent
with previous studies (Argyropoulos et al., 2002; Griez & Van den
Hout, 1983; Kaye et al., 2004; Kaye, Young, Mathias, Watson, &
Lightman, 2006; Richey et al., 2010; Shufflebotham et al., 2009;
Wetherell et al., 2006). With regard to the diastolic blood pressure,
an immediate CO2-induced increase has also been reported pre-
viously in some (Griez & Van den Hout, 1983; Kaye et al., 2006;
Richey et al., 2010), but not all studies (Argyropoulos et al., 2002;
Bailey et al., 2005; Bailey, Papadopoulos, Lingford-Hughes, & Nutt,
2007; Kaye et al., 2004; Papadopoulos et al., 2010). The discrep-
ancies between our results and those of other studies might be
explained by differential methodology. For instance, a single vital
capacity breath of 35% CO2 (Argyropoulos et al., 2002; Kaye et al.,
2004), in contrast to a double vital capacity breath in the present
study, exposure to lower CO2 concentrations such as 7.5% for 20 min
(Bailey et al., 2005, 2007; Papadopoulos et al., 2010), and differ-
ences in terms of sample size (Argyropoulos et al., 2002; Bailey
et al., 2005), as well as methods of analysis (Gorman et al., 1990)
can contribute to varying results. In comparison with these other
studies the present study has several advantages. Since it has been
shown that in healthy volunteers specifically a double breath of 35%
CO2 provokes emotions and panic symptoms resembling a real-life
PA (Griez et al., 2007; Schruers et al., 2011), our approach may  be
seen as more robust to induce a panic response with a rapid onset.
Moreover, our large sample size on top of measuring the effects
of four concentrations of CO2 in each subject presumably yielded
more reliable results. In addition, analytical methods such as calcu-
lating averages over 15 s intervals (Gorman et al., 1990) can mask
small and brief fluctuations, resulting in a possibly inappropriate
interpretation of the results. This emphasizes the need for contin-
uous monitoring and analysis of the data obtained in short time
frame such as twice per second as in the present study.
With regard to heart rate, contrary to our hypothesis, the out-
come measures did not increase in a dose-dependent manner and
were, in general, hardly affected by any CO2 concentration. More
specifically, the AUC of the heart rate decreased with increasing
CO2 concentration, with the strongest effect in the 17.5% CO2 con-
dition. This effect might be compensatory to the increased blood
pressure and was also observed in previous studies using a sin-
gle (Argyropoulos et al., 2002; Kaye et al., 2004; Shufflebotham
et al., 2009; Wetherell et al., 2006) and a double vital breath of 35%
CO2 (Verschoor & Markus, 2011). However, other studies reported
an increase in heart rate (Bailey et al., 2005; Poonai et al., 2000;
Richey et al., 2010; Sasaki et al., 1996) or did not find any effect
(Bailey et al., 2007; Bystritsky & Shapiro, 1992). These discrepancies
may  be again explained by differential methodology as previously
described. Interestingly, a clear dose-dependent increase in the
heart rate variation was observed, i.e., the level of heart rate fluc-
tuations increased with a rising dosage of CO2. This observation
suggests that panic symptoms such as palpitations may  be more
related to fluctuations in heart rate rather than to a mere increase
in frequency.
In  the present study, the increases in blood pressure and heart
rate were comparable in men  and women in all CO2-enriched air
conditions. Similarly, Kelly et al. (2006) failed to reliably discrim-
inate between men  and women  when assessing the response to
12 inhalations of 20% CO2 for 20 s. However, this result is not
uniform as some other studies did report sex differences in the
physiological response to inhaling CO2. For instance, in a recent
study by Nillni et al. (2012), when administering 10% CO2 for 4 min,
women had higher heart rate levels during the inhalation when
compared to men, an effect which could not be attributed to base-
line differences in heart rate. This result is in line with a previous
study using the same concentration of CO2 and administration time
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urther clarify whether women are more physiologically reactive to
aboratory-induced PAs than men.
.3. Correlations between self-reports and cardiovascular
utcome measures
Correlation analyses between self-report measures and car-
iovascular outcomes revealed the most significant relationship
etween fear and heart rate variation. As previously mentioned,
his observation may  imply that fluctuations caused by a homeo-
tatic disturbance play a more important role in CO2-induced fear
han, e.g., an increase in heart rate itself. In addition to heart rate,
ear and discomfort were associated with most of the outcomes
f the diastolic blood pressure, particularly the AUC and the CO2-
nduced peak. Correlation analysis of a previous study by Bailey
t al. (2003) did not reveal any relationship between blood pres-
ure or heart rate and fear. Evidently, analyzing several outcome
easures such as the AUC, peak, and variation in distinct cardio-
ascular parameters in a temporal manner gives a more detailed
iew into the complex relationship between physiology and panic,
hereby revealing correlations that might not be detected when
ocusing on, for instance, the mean blood pressure and heart rate
lone.
Regarding the systolic blood pressure, fewer correlations with
elf-reports were present. This result, in combination with the
bservation that the diastolic blood pressure mimicked the degree
f fear, discomfort, and panic symptoms, suggests that the dia-
tolic blood pressure is the most favorable parameter to assess the
hysiological response to CO2.
.4. Limitations
Various factors are known to have a potential influence on the
ndividual response to inhaling CO2. In the present study, several
onfounding effects were minimized using strict exclusion criteria.
or instance, heavy smokers (Abrams et al., 2008; Knuts et al., 2010),
lcohol users (Cosci et al., 2005; Kushner et al., 1996) and users of
rugs/medications that are considered to have an effect on the ner-
ous or cardiovascular system were excluded during the screening
rocedure. In addition, subjects were instructed to refrain from cof-
ee on all test days to avoid possible anxiogenic effects of caffeine
Nardi et al., 2007; Vilarim et al., 2011). However, other poten-
ial confounders such as anxiety sensitivity (Blechert et al., 2013;
chmidt & Zvolensky, 2007) and physical activity (Esquivel et al.,
012; Smits et al., 2009) were not assessed. Moreover, due to prac-
ical reasons, we also did not control for menstrual cycle phase
Perna, Brambilla, Arancio, & Bellodi, 1995). Including those mea-
urements would improve the study design and may  increase the
eliability of the results.
.5. Panic as an instance of a primal emotion
We  have previously proposed (in line with Denton, 2006;
enton et al., 2009) that PAs are the expression of a primal emo-
ion (Colasanti et al., 2012). The interoceptor-driven sensation of
 bodily disturbance linked to immediate threat of the individ-
al leads to a compelling intention (i.e., adaptive homeostatic
esponse) to protect the individual against that vital threat. In
ccordance with this notion, we showed in the present study that
elf-reports, representing sensations that emerge into conscious-
ess, and the physiological response to CO2 are closely related. The
resent results are in accordance with previous data showing that
euronal activation of (para)limbic brain areas and deactivation
f other areas in response to CO2 are congruent with the pattern
bserved with a subjective experience of other primal emotions
uch as extreme thirst, hunger or pain (Liotti et al., 2001). Together,hology 94 (2013) 331– 340
the close relationship of self-reports and physiology in the present
study as well as the congruency of (de)activation of brain struc-
tures in response to CO2 in other primal emotions supports our
proposition that PAs are an instance of a primal emotion.
4.6. Clinical implications and future perspectives
The symptoms experienced during a PA such as palpitations,
chest pain, breathing difficulties, and dizziness are not specific or
automatically attributable to a PA. Up to 20% of patients suffering
from chest pain and seeking help in emergency departments meet
the official criteria for PD (Huffman & Pollack, 2003). This obser-
vation emphasizes the need for a fast and refined assessment of
PAs.
In the present study, the overall heart rate response to inhaling
CO2 was not strongly affected. The variation in heart rate, how-
ever, increased dose-dependently. This may  indicate that panic
symptoms such as palpitations are associated with heart rate fluc-
tuations (i.e., brief disturbances in the homeostasis) rather than, for
instance, a mere increase in frequency. Furthermore, among the
assessed cardiovascular parameters, the diastolic blood pressure
appears to be the most sensitive and robust measure, deeming it a
putative biomarker for (experimentally induced) panic. Therefore,
we propose that diastolic blood pressure measurements should be
included in future studies to complement other measures such as
self-reports.
It has been previously demonstrated that CO2 inhalation is a
reliable technique to provoke intense, but transient, fear and/or
discomfort and various sensations in PD patients as well as healthy
subjects. These sensations closely resemble the symptomatology of
real-life PAs. In PD patients, a single vital capacity breath of 35% CO2
is sufficient, whereas in healthy subjects, a double breath of 35% CO2
is particularly effective in triggering those symptoms. These obser-
vations suggest the existence of a CO2-reactivity continuum based
on a common mechanism, thereby opening the possibility of refer-
ring to healthy subjects for the study of panic, which has several
advantages. First, patients do not need to be burdened unnecessar-
ily. Second, the potency of new therapies to modulate the response
to CO2 can also be evaluated in healthy volunteers before even-
tually testing promising interventions in patients with PD. Third,
sampling and testing healthy volunteers provides insights into
the fundamental mechanisms underlying CO2-reactivity and panic,
without possible masking effects of comorbidity and medication.
Bouton, Mineka, and Barlow (2001) proposed that conditioned
anxiety about future PAs in response to extero- or interoceptive
cues is a key process in the progression of PAs into PD.  This pro-
cess can also be best modeled in healthy subjects, because PD
patients have progressed beyond the initial conditioning. Exper-
imentally, the use of interoceptive cues is challenging given their
internal nature. As inhaling 35% CO2 reliably causes an immediate
intense emotional response, we recently used CO2 inhalation as
unconditioned stimulus to examine selective interoceptive condi-
tioning (De Cort, Griez, Buchler, & Schruers, 2012). In that study, we
showed that CO2 may  be a valuable agent for establishing an effec-
tive interoceptive cue in conditioning research. This is particularly
interesting to investigate the role of interoceptive conditioning in
the development from spontaneous PAs to PD. In future studies, it
would be therefore worthwhile to also study patients with anxiety
disorders to examine the difference between the adaptive nature of
fear conditioning and the dysfunctional nature of anxiety disorders
(Beckers, Krypotos, Boddez, Effting, & Kindt, 2013).
Furthermore, the use of CO2 as an interoceptive cue may
be a promising technique in the treatment of PD. In spite of
its effectiveness (Sanchez-Meca, Rosa-Alcazar, Marin-Martinez, &
Gomez-Conesa, 2010), interoceptive exposure is not yet commonly
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nduction exercises such as hyperventilation or spinning are most
ften used. However, these exercises only induce a fraction of
he panic symptoms (Antony, Ledley, Liss, & Swinson, 2006; Lee
t al., 2006). Therefore, we propose to include 35% CO2 inhalation
n interoceptive exposure therapy. The congruency with naturally
ccurring PAs will putatively increase the learning of how to deal
ith future PAs and thereby improve the effectiveness of cognitive
ehavioral therapies.
While CO2 inhalation in humans is a well-established experi-
ental model for panic and increased the knowledge about that
sychobiological phenomenon, it is limited in its potential to con-
ribute to molecular insights. These can be better assessed in animal
esearch. In a recent rodent study (Ziemann et al., 2009), it was
hown that exposure to CO2 also triggers fear behavior in mice. Var-
ous techniques were used to provide a molecular substrate for this
ffect. It was demonstrated that the fear response is dependent on
he pH-sensitive ion channel ASIC1a located within the amygdala.
ore specifically, CO2 reduces the pH within the amygdala, thereby
timulating amygdalar ASIC1a and triggering fear behavior. Knock-
ut of the gene encoding ASIC1a blunted this particular effect. Main
utcome measures in this study were a series of behavioral tests. In
rder to be relevant for translation into a human perspective, ani-
al  studies should ideally use stimuli and outcome measures that
re as similar as possible to those of human studies. In most human
anic provocation studies, symptom reports are used as outcome. It
s obvious that observed behavior in animals and symptom reports
n humans are not interchangeable. Physiology, however, is mea-
urable in both rodents and humans, which makes it a valuable
ddition to assess the response to CO2 in different species. We
herefore propose to extend the methods from the present study to
nimal studies, where physiological outcome measures are not yet
ommonly used. Thereby, the comparability between animal and
uman research can be considerably improved, thus contributing
o a better translation of knowledge gained in the laboratory back
o the clinic.
.7. Conclusion
In sum, the present study addressed identifiable shortcomings
n previous studies such as small sample sizes, and methodological
s well as technical limitations, to comprehensively investigate the
eactivity to CO2 in healthy volunteers. The results show a dose-
ependent subjective emotional and panic symptom response to
O2. This pattern was best represented by the diastolic blood pres-
ure, indicating a better sensitivity and discriminability compared
o the systolic blood pressure and heart rate. Further, particularly
ignificant correlations were found between self-reports and heart
ate variation as well as several outcome measures of the diastolic
lood pressure. These results indicate that the combination of both
ubjective self-reports and cardiovascular measures is a promising
ethod to obtain a more refined and reliable assessment of PAs and
o assess PAs in all its aspects as an instance of a primal emotion.
articularly the diastolic blood pressure appears to be a robust and
utative biomarker to assess the reactivity to CO2 in future studies.
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